BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 15042689)

  • 1. Strongyloidiasis in patients at a comprehensive cancer center in the United States.
    Safdar A; Malathum K; Rodriguez SJ; Husni R; Rolston KV
    Cancer; 2004 Apr; 100(7):1531-6. PubMed ID: 15042689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation.
    Wirk B; Wingard JR
    Transpl Infect Dis; 2009 Apr; 11(2):143-8. PubMed ID: 19144095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strongyloides stercoralis hyperinfection in systemic lupus erythematosus and the antiphospholipid syndrome.
    Mora CS; Segami MI; Hidalgo JA
    Semin Arthritis Rheum; 2006 Dec; 36(3):135-43. PubMed ID: 16949135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for strongyloidiasis hyperinfection and clinical outcomes.
    Asdamongkol N; Pornsuriyasak P; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):875-84. PubMed ID: 17333728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infection due to Strongyloides stercoralis: epidemiological, clinical, diagnosis findings and outcome in 30 patients].
    Corti M; Villafañe MF; Trione N; Risso D; Abuín JC; Palmieri O
    Rev Chilena Infectol; 2011 Jun; 28(3):217-22. PubMed ID: 21879146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection.
    Segarra-Newnham M
    Ann Pharmacother; 2007 Dec; 41(12):1992-2001. PubMed ID: 17940124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies.
    Schaffel R; Nucci M; Portugal R; Castro MB; Ferreira SB; Almeida L; Spector N; Pulcheri W
    Clin Infect Dis; 2000 Sep; 31(3):821-2. PubMed ID: 11017840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia.
    Einsiedel L; Fernandes L
    Intern Med J; 2008 Sep; 38(9):697-703. PubMed ID: 19143887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal strongyloidiasis: a diagnosis frequently missed in the tropics.
    Agrawal V; Agarwal T; Ghoshal UC
    Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):242-6. PubMed ID: 18804829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Strongyloides stercoralis hyperinfection].
    Gelber M; Rodrig J
    Harefuah; 1996 Jan; 130(2):90-2, 143. PubMed ID: 8846985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thiabendazole for the control of Strongyloides stercoralis infection in a hyperendemic area in Peru].
    Marcos L; Terashima A; Samalvides F; Alvarez H; Lindo F; Tello R; Canales M; Demarini J; Gotuzzo E
    Rev Gastroenterol Peru; 2005; 25(4):341-8. PubMed ID: 16333389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strongyloidiasis in the Northern Territory. Under-recognised and under-treated?
    Fisher D; McCarry F; Currie B
    Med J Aust; 1993 Jul; 159(2):88-90. PubMed ID: 8336608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of Strongyloides stercoralis infection in an endemic area of the United States.
    Milder JE; Walzer PD; Kilgore G; Rutherford I; Klein M
    Gastroenterology; 1981 Jun; 80(6):1481-8. PubMed ID: 7227772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodialysis and strongyloidiasis: a presumed cause of eosinophilia able to mask the other].
    Saïd S; Nevez G; Morinière P; Fournier A; Raccurt CP
    Nephrologie; 1999; 20(6):343-6. PubMed ID: 10592937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
    Peters L; McCarthy AE; Faught C
    Int J Infect Dis; 2009 Nov; 13(6):e501-3. PubMed ID: 19501008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infection by Strongyloides stercoralis in the county of Safor, Spain].
    Cremades Romero MJ; Igual Adell R; Ricart Olmos C; Estellés Piera F; Pastor-Guzmán A; Menéndez Villanueva R
    Med Clin (Barc); 1997 Jul; 109(6):212-5. PubMed ID: 9289550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aseptic purulent meningitis in two patients co-infected by HTLV-1 and Strongyloides stercoralis].
    Foucan L; Genevier I; Lamaury I; Strobel M
    Med Trop (Mars); 1997; 57(3):262-4. PubMed ID: 9513154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical manifestations of strongyloidiasis in southern Taiwan.
    Tsai HC; Lee SS; Liu YC; Lin WR; Huang CK; Chen YS; Wann SR; Tsai TH; Lin HH; Yen MY; Yen CM; Chen ER
    J Microbiol Immunol Infect; 2002 Mar; 35(1):29-36. PubMed ID: 11950117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.
    Pacanowski J; Santos MD; Roux A; LE Maignan C; Guillot J; Lavarde V; Cornet M
    Am J Trop Med Hyg; 2005 Jul; 73(1):122-4. PubMed ID: 16014846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrapulmonary tuberculosis active infection misdiagnosed as cancer: Mycobacterium tuberculosis disease in patients at a Comprehensive Cancer Center (2001-2005).
    Aisenberg GM; Jacobson K; Chemaly RF; Rolston KV; Raad II; Safdar A
    Cancer; 2005 Dec; 104(12):2882-7. PubMed ID: 16245341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.